Clinical Study
Combination of Triple Therapy and Chronic PPI Use May Decrease Risk of Colonic Adenomatous Polyps in Helicobacter pylori Infection
Table 3
Multivariate analysis of risk factors affecting development of adenomatous polyps in H. pylori-positive patients.
| Multivariate analysis | ā | Crude OR | CI | Adjusted OR | CI |
| Age ā„ 50 | 3.13 | 1.81 | 5.65 | 2.76 | 1.59 | 4.77 | Sex | 1.83 | 1.19 | 2.81 | 1.79 | 1.17 | 2.73 | Triple therapy | 0.52 | 0.34 | 0.801 | 0.69 | 0.44 | 1.07 | Chronic PPI use | 0.484 | 0.31 | 0.76 | 0.69 | 0.43 | 1.09 | Triple therapy and chronic PPI use | 0.36 | 0.22 | 0.78 | 0.26 | 0.10 | 0.646 |
|
|